GeneDx Holdings share price logo

GeneDx Holdings

NASDAQ: WGS

Mid Cap

$86.33

-2.91

(-3.26%)

as on

GeneDx Holdings Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $85.92
    $89.74
    downward going graph

    0.47%

    Downside

    3.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $32.21
    $170.87
    downward going graph

    62.69%

    Downside

    97.93%

    Upside

    downward going graph

GeneDx Holdings share price movements today

Previous Close
$89.24
Open
$88.79
Volume
438.3K
Market Cap
$2.7B
Day's Low - High
$85.92 - $89.74
52 Week Low - High
$32.21 - $170.87

GeneDx Holdings Historical Returns

1 Month Return
+ 44.21 %
3 Month Return
+ 77.95 %
1 Year Return
-30.82 %
3 Year Return
+ 1989.93 %
5 Year Return
0 %

GeneDx Holdings Stock Fundamentals & Key Indicators

Check GeneDx Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-3.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-21.74

Industry PE ratio

41.77

PEG Ratio

-0.01211570687377139

EBITDA

-76.4M

Revenue (TTM)

454.4M

Profit Margin

68.20%

Return On Equity TTM

-38.72%

GeneDx Holdings Stock Valuation

Track how GeneDx Holdings P/E has moved over time to understand its valuation trends.

GeneDx Holdings in the last 5 years

  • Overview

  • Trends

Lowest (-178.16x)

December 31, 2025

Today (-178.16x)

December 31, 2025

Industry (41.77x)

December 31, 2025

Highest (-0.16x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -178.16x

GeneDx Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GeneDx Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
GeneDx Holdings image
GeneDx Holdings
BUY$2.7BNA-21.7468.20%NA
Natera image
Natera
BUY$48.8B187.11%-228.5165.30%NA
Agilent image
Agilent
BUY$43.3B-9.27%31.0819.55%52.81%
Thermo Fisher image
Thermo Fisher
BUY$232.3B14.98%3240.37%0.3%
Danaher image
Danaher
BUY$151.8B-32.41%38.2258.51%0.67%

Stock Returns calculator for GeneDx Holdings Stock including INR - Dollar returns

The GeneDx Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

GeneDx Holdings investment value today

Current value as on today

₹72,392

Returns

-₹27,608

(-27.61%)

Returns from GeneDx Holdings Stock

-₹33,078 (-33.08%)

Dollar Impact

₹5,469 (+5.47%)

Analyst Recommendation on GeneDx Holdings Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for GeneDx Holdings. Average target price of $90.44

GeneDx Holdings Share Price Target

Get share price movements and forecasts by analysts on GeneDx Holdings.

What analysts predicted

4.54%UPSIDE

Target Price

$90.44

Current Price

$86.33

Analyzed by

7 Analysts

Target

$90.44

GeneDx Holdings target price $90.44, a slight upside of 4.54% compared to current price of $86.33. According to 7 analysts rating.

Indian Investors' Interest in GeneDx Holdings Stock

Search interest for GeneDx Holdings Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

GeneDx Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
62
70
76
95
87
102
116
120
102
114
Gross Profit
37
42
47
66
58
70
84
78
68
78
Operating Income
-13
-10
-7
8
-4
8
-3
-13
-26
-17
EBITDA
-14
-23
-1
11
0
17
0
-10
-54
-10
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
5
5
5
5
5
6
6
6
6
6
Income Before Tax
-20
-29
-8
5
-6
10
-7
-18
-62
-18
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-20
-29
-8
5
-6
10
-7
-17
-63
-17
Net Profit Margin
59.93%
60.91%
62.22%
69.22%
67.13%
69.04%
72.40%
65.23%
66.71%
68.37%

GeneDx Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
179
212
234
202
305
427
Gross Profit
4
-16
-26
90
194
298
Operating Income
-241
-446
-667
-180
-23
-11
EBITDA
-227
-220
-398
-136
-27
6
Interest Expense
2
2
3
-
3
2
Depreciation
11
21
59
33
21
25
Income Before Tax
-241
-245
-598
-176
-52
-21
Income Tax Expense
-
-
-49
0
0
0
Net Income
-241
-245
-548
-175
-52
-21
Net Profit Margin
2.25%
-7.82%
-11.40%
44.43%
63.64%
69.74%

GeneDx Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-20
-29
-8
5
-6
10
-7
-17
-63
-17
Operating Cash Flow
-16
-4
-4
-3
10
10
15
-3
-32
-28
Investing Cash Flow
0
-22
-7
0
-9
-36
-4
-11
-17
-5
Financing Cash Flow
0
0
13
31
13
0
10
23
38
1
Change in Cash
-16
-27
1
27
14
-25
21
9
-11
-33

GeneDx Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-241
-245
-548
-175
-52
-21
Operating Cash Flow
-93
-190
-319
-180
-28
33
Investing Cash Flow
-31
-20
-141
-43
-30
-61
Financing Cash Flow
129
493
197
186
44
48
Change in Cash
3
282
-263
-37
-14
19

Mutual Funds that own GeneDx Holdings Stock

Check out the Mutual Funds with significant holdings in GeneDx Holdings.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.812476%
838752
SMALLCAP World Fund Inc
1.540744%
459489
MUTUAL FUND SERIES TRUST
1.531888%
456848
IVY FUNDS
0.893203%
266376
Putnam Funds Trust
0.757665%
225955
See all

Global Institutional Holdings in GeneDx Holdings

Funds
Holdings
Keith Meister
16.04%
Cathie Wood
5.4%
ARK
5.17%
Vanguard
3.55%
Peter Durbin
2.97%
See all

GeneDx Holdings News & Key Events

  • img

    Today's Timeline - 02 March

    Mon, 05:32 PM

    -

    GeneDx secures a $100 million term loan from Blackstone to refinance existing debt and optimize its balance sheet.

Insights on GeneDx Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, WGS stock has moved up by 1797.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 102.25M → 114.43M (in $), with an average increase of 10.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -63.31M → -17.74M (in $), with an average increase of 256.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WGS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 93.9% return, outperforming this stock by 127.2%

About GeneDx Holdings

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
OrganisationGeneDx Holdings
HeadquartersNorth Tower, Stamford, CT, United States, 06902
IndustryDiagnostics & Research
CEOMs. Katherine A. Stueland
E-voting on sharesClick here to vote

Key Management of GeneDx Holdings

Name

Title

Ms. Katherine A. Stueland

CEO & Director

Mr. Kevin Feeley CPA

Chief Financial Officer

Ms. Sabrina V. Dunbar

Director of Investor Relations & Communications

Ms. Jami Biliboaca

Chief People Officer

Ms. Melanie Duquette

Chief Growth Officer

Ms. Linda Genen M.D., M.P.H.

Chief Medical Officer

Dr. Bryan M. Dechairo Ph.D.

Chief Technology & Innovation Officer

Mr. Mark A. Gardner M.B.A.

President

Ms. Heidi C. Chen J.D.

Chief Legal Officer

Ms. Lisa Gurry

Chief Business Officer

FAQs

What is GeneDx Holdings share price today?

GeneDx Holdings share price today is $86.33 as on at the close of the market. GeneDx Holdings share today touched a day high of $89.74 and a low of $85.92.

What is the 52 week high and 52 week low for GeneDx Holdings share?

GeneDx Holdings share touched a 52 week high of $170.87 on and a 52 week low of $32.21 on . GeneDx Holdings stock price today i.e. is closed at $86.33,which is 49.48% down from its 52 week high and 168.02% up from its 52 week low.

What is GeneDx Holdings's market capitalisation today?

GeneDx Holdings market capitalisation is $0.00T as on .

How to invest in GeneDx Holdings Stock (WGS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GeneDx Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in GeneDx Holdings Shares that will get you 0.0174 shares as per GeneDx Holdings share price of $86.33 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy GeneDx Holdings Stock (WGS) from India?

Indian investors can start investing in GeneDx Holdings (WGS) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in GeneDx Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on GeneDx Holdings share’s latest price of $86.33 as on August 29, 2026 at 8:46 am IST, you will get 0.1158 shares of GeneDx Holdings. Learn more about fractional shares .